卵巢癌合并重症肌无力疾病的发病机理探讨

Study on the Pathogenesis of Ovarian Cancer With Myasthenia Gravis

卵巢癌是严重威胁女性健康的恶性肿瘤之一,虽发病率在我国仅次于宫颈癌、子宫内膜癌列居第三,但死亡率却稳居首位。目前,以全面分期手术及肿瘤细胞减灭术、化疗(紫杉醇+铂类)等为该病规范化综合治疗的现状;即使一线治疗中控制率较高,但复发率及诸多合并症的出现,仍使得卵巢癌成为生存率最低的妇科恶性肿瘤。本文通过报道2012年10月—2016年9月我院收治的16例卵巢癌合并重症肌无力患者作为研究对象,浅谈卵巢癌与重症肌无力的疾病发生关系。

Ovarian cancer is one of the malignant tumor that serious threat to women＇s health, although the incidence after cervical cancer and endometrial cancer in our country, but the mortality rate is the highest. The comprehensive methods completed surgical staging and maximal resection combined with chemotherapy is the standardized therapy at present. Even if a higher efficiency in the first-line treatment, the recurrence rate and many complications still makes ovarian cancer was the lowest survival rate in gynecologic malignant tumor. This paper reports the clinical symptoms of 16 cases of ovarian cancer merger myasthenia gravis from October 2012 to September 2016 in our hospital, to introduction the relationship between ovarian cancer and myasthenia gravis.